dulaglutide in reducing CV risk in patients with T2DM and superiority in reducing body weight and improving metabolic parameters #semaglutide #tirzepatide #cardiovascularcomplications #bodyweight #diabetes #obesity #MACE #CKD To view or add a comment, sign in Injection is only one part in obesity management .Real long term success depends on preserving muscle with protein intake and strength training
Nausea remains the most frequently reported hurdle
Low sex drive is not listed as a side effect on Ozempics website , but some users do report a drop in their libido while on the medication
Simultaneously, its GLP-1 activity suppresses the release of glucagon, which reduces the liver's output of glucose, further contributing to lower fasting and postprandial glucose levels
Once the quiz is complete, youll be given one of six protocols, each made up of supplements designed to address the specific challenging block you from losing weight
While the rate of GLP-1 prescriptions labeled for type 2 diabetes were about the same as June 2024 (+4.0%), the rate of prescriptions for GLP-1 medications labeled for obesity increased substantially in September 2024 compared to June 2024 (+32.3%)
